Management of Asymptomatic Patients With Textured Surface Breast Implants

Patricia A McGuire; Anand K Deva; Caroline A Glicksman; William P Adams Jr; Melinda J Haws

doi:10.1093/asjof/ojz025

Management of Asymptomatic Patients With Textured Surface Breast Implants

Aesthet Surg J Open Forum. 2019 Aug 22;1(3):ojz025. doi: 10.1093/asjof/ojz025. eCollection 2019 Sep.

Authors

Patricia A McGuire^{1

2

3

4}, Anand K Deva¹, Caroline A Glicksman², William P Adams Jr³, Melinda J Haws⁴

Affiliations

¹ Department of Plastic and Reconstructive Surgery, Macquarie University, Sydney, Australia.
² Clinical Assistant Professor of Plastic Surgery, Hackensack Meridian School of Medicine at Seton Hall, Nutley, NJ.
³ Department of Plastic Surgery, and Program Director of the Aesthetic Surgery Fellowship at UTSW, University of Texas Southwestern, Dallas, TX.
⁴ Clinical Assistant Professor of Plastic Surgery, Vanderbilt University, Nashville, TN.

Abstract

With the recent voluntary recall by Allergan of their Biocell textured implants, many plastic surgeons are left with questions of how to best manage asymptomatic patients who have concerns about having these devices. We realized that there is no clear, published recommendations or scientific data to guide surgeons on how to discuss options with their patients and recommendations for surgical management in this uncharted territory. Using available literature and personal experience, we answer the most common questions we are hearing from our plastic surgery colleagues.